Arena Pharmaceuticals, Inc. (ARNA)

1.39
NASDAQ
Prev Close 1.39
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.20 / 2.16
Exchange NASDAQ
Shares Outstanding 307.73B
Market Cap 418.51M
Div & Yield N.A. (N.A)

Latest News

Arena Pharmaceuticals Announces Multiple Presentations At ASPET 2017 At Experimental Biology

Arena Pharmaceuticals Announces Multiple Presentations At ASPET 2017 At Experimental Biology

- Data to highlight etrasimod, Arena's orally available next generation sphingosine-1-phosphate (S1P) receptor modulator for the potential treatment of autoimmune diseases -

How to Trade Wednesday's Most Active Stocks: Lloyds, Arena Pharma, MSCI and More

How to Trade Wednesday's Most Active Stocks: Lloyds, Arena Pharma, MSCI and More

Here's how to trade six of the most active names on the market today.

Biotech Premarket Movers: Arena, Immunomedics, Aralez

Biotech Premarket Movers: Arena, Immunomedics, Aralez

Arena Pharmaceuticals, Immunomedics and Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Wednesday.

Interesting ARNA Call Options For October 20th

Interesting ARNA Call Options For October 20th

Investors in Arena Pharmaceuticals Inc saw new options become available this week, for the October 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

You Can Also Get High on Marijuana Stocks -- Here's How

You Can Also Get High on Marijuana Stocks -- Here's How

Everyone else is doing it.

Arena Pharmaceuticals And Eisai Amend Marketing And Supply Agreement For BELVIQ Globally

Arena Pharmaceuticals And Eisai Amend Marketing And Supply Agreement For BELVIQ Globally

Arena Expects to Receive $23 Million of Cash Payments and Over $80 Million of Potential Cost Relief and Will Continue to Focus on Its Clinical Programs

July 2017 Options Now Available For Arena Pharmaceuticals (ARNA)

July 2017 Options Now Available For Arena Pharmaceuticals (ARNA)

Investors in Arena Pharmaceuticals Inc saw new options begin trading today, for the July 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ARNA April 2017 Options Begin Trading

ARNA April 2017 Options Begin Trading

Investors in Arena Pharmaceuticals Inc saw new options become available today, for the April 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

How Will Arena Pharmaceuticals (ARNA) Stock React to Q2 Miss?

How Will Arena Pharmaceuticals (ARNA) Stock React to Q2 Miss?

Arena Pharmaceuticals (ARNA) posted a wider loss than analysts projected after today's market close.

Arena Pharmaceuticals (ARNA) Stock Gains as FDA Approves Weight-Loss Drug

Arena Pharmaceuticals (ARNA) Stock Gains as FDA Approves Weight-Loss Drug

Arena Pharmaceuticals (ARNA) stock is trading higher after receiving FDA approval for a new extended release weight-loss pill.